Back to today’s briefing

Story perspectives

Delaying Hepatitis B Vaccine Risks Newborn Infections, Experts Warn

12/8/2025

36 3 Full Breakdown

Summary

Story summary

The American Academy of Pediatrics warns that delaying the Hepatitis B vaccine for newborns from birth to two months could increase infection risk.
Dr. Scott Gottlieb emphasized that 90% of infected newborns develop chronic conditions.
He noted that many mothers are not tested for Hepatitis B, risking false negatives.
Parents are concerned about shifting vaccine guidelines, which they believe are politically motivated rather than science-based.

History

Historical Context

In 1991, the CDC recommended the Hepatitis B vaccine for all newborns to address rising infection rates. By 2018, around 90% of infants infected with Hepatitis B developed chronic liver disease, underscoring the vaccine's importance. Current debates over vaccination delays reflect historical tensions influenced by political factors, emphasizing the need for timely immunization to safeguard public health and prevent long-term complications.

1 of 2

Story summary

The American Academy of Pediatrics warns that delaying the Hepatitis B vaccine for newborns from birth to two months could increase infection risk.
Dr. Scott Gottlieb emphasized that 90% of infected newborns develop chronic conditions.
He noted that many mothers are not tested for Hepatitis B, risking false negatives.
Parents are concerned about shifting vaccine guidelines, which they believe are politically motivated rather than science-based.

1 / 2